(Q36029282)

11 August 2017

1 reference

title

Are new vitamin D analogues in renal bone disease superior to calcitriol? (English)

1 reference

11 August 2017

0 references

1 reference

1

Isidro B Salusky

1 reference

11 August 2017

publication date

3 February 2005

1 reference

11 August 2017

1 reference

11 August 2017

volume

20

1 reference

11 August 2017

issue

3

1 reference

11 August 2017

page(s)

393-398

1 reference

https://scigraph.springernature.com/pub.10.1007/s00467-004-1788-2

11 August 2017

exact match

0 references

cites work

PTH 1-84 and PTH "7-84" in the noninvasive diagnosis of renal bone disease

1 reference

12 December 2020

Prospective trial of pulse oral versus intravenous calcitriol treatment of hyperparathyroidism in ESRD

1 reference

12 December 2020

Intravenous calcitriol for treatment of hyperparathyroidism in children on hemodialysis

1 reference

12 December 2020

22-Oxacalcitriol ameliorates high-turnover bone and marked osteitis fibrosa in rats with slowly progressive nephritis

1 reference

12 December 2020

1 alpha-Hydroxyvitamin D2 is less toxic than 1 alpha-hydroxyvitamin D3 in the rat.

1 reference

12 December 2020

Doxercalciferol safely suppresses PTH levels in patients with secondary hyperparathyroidism associated with chronic kidney disease stages 3 and 4.

1 reference

12 December 2020

Effect of alfacalcidol on natural course of renal bone disease in mild to moderate renal failure

1 reference

12 December 2020

Pharmacokinetics and efficacy of pulse oral versus intravenous calcitriol in hemodialysis patients

1 reference

12 December 2020

Quantitative bone histology in children with chronic renal failure

1 reference

12 December 2020

The noncalcemic analogue of vitamin D, 22-oxacalcitriol, suppresses parathyroid hormone synthesis and secretion

1 reference

12 December 2020

Comparison of intact, midregion, and carboxy terminal assays of parathyroid hormone for the diagnosis of bone disease in hemodialyzed patients

1 reference

12 December 2020

Renal osteodystrophy in children: the role of vitamin D, phosphorus, and parathyroid hormone

1 reference

12 December 2020

Treatment of secondary hyperparathyroidism of predialysis chronic renal failure with low doses of 1,25(OH)2D3: humoral and histomorphometric results

1 reference

12 December 2020

Growth in children with chronic renal failure on intermittent versus daily calcitriol

1 reference

12 December 2020

Metabolic studies of low protein diets in uremia. II. Calcium, phosphorus and magnesium

1 reference

12 December 2020

A new analog of 1,25-(OH)2D3, 19-NOR-1,25-(OH)2D2, suppresses serum PTH and parathyroid gland growth in uremic rats without elevation of intestinal vitamin D receptor content

1 reference

12 December 2020

Intact parathyroid hormone overestimates the presence and severity of parathyroid-mediated osseous abnormalities in uremia

1 reference

12 December 2020

Increased Growth after Long-Term Oral 1α,25-Vitamin D3in Childhood Renal Osteodystrophy

1 reference

12 December 2020

The mechanism for the disparate actions of calcitriol and 22-oxacalcitriol in the intestine

1 reference

12 December 2020

Suppression of parathyroid hormone secretion in hemodialysis patients: comparison of paricalcitol with calcitriol.

1 reference

12 December 2020

Clinical epidemiology of cardiovascular disease in chronic renal disease

1 reference

12 December 2020

Highly sensitive two-site immunoradiometric assay of parathyrin, and its clinical utility in evaluating patients with hypercalcemia.

1 reference

12 December 2020

Localisation of aluminium by histochemical and electron probe x-ray microanalytical techniques in bone tissue of cases of renal osteodystrophy

1 reference

12 December 2020

Effect of 22-oxacalcitriol on bone histology of hemodialyzed patients with severe secondary hyperparathyroidism

1 reference

12 December 2020

Bone disease in pediatric patients undergoing dialysis with CAPD or CCPD

1 reference

12 December 2020

Use of active vitamin D sterols in patients with chronic kidney disease, stages 3 and 4.

1 reference

12 December 2020

Regulation of parathyroid hormone gene expression by hypocalcemia, hypercalcemia, and vitamin D in the rat

1 reference

12 December 2020

Biochemical markers of renal osteodystrophy in pediatric patients undergoing CAPD/CCPD.

1 reference

12 December 2020

Renal osteodystrophy in children on maintenance haemodialysis

1 reference

12 December 2020

Randomized, double-blind, placebo-controlled, dose-titration, phase III study assessing the efficacy and tolerability of lanthanum carbonate: a new phosphate binder for the treatment of hyperphosphatemia

1 reference

12 December 2020

Effective suppression of parathyroid hormone by 1 alpha-hydroxy-vitamin D2 in hemodialysis patients with moderate to severe secondary hyperparathyroidism

1 reference

12 December 2020

Improved assessment of bone turnover by the PTH-(1-84)/large C-PTH fragments ratio in ESRD patients

1 reference

12 December 2020

Catch-up growth with normal parathyroid hormone levels in chronic renal failure

1 reference

12 December 2020

1,25-dihydroxyvitamin D3 and 22-oxacalcitriol prevent the decrease in vitamin D receptor content in the parathyroid glands of uremic rats

1 reference

12 December 2020

The spectrum of bone disease in end-stage renal failure--an evolving disorder

1 reference

12 December 2020

Effects of 25-hydroxycholecalciferol on bone lesions of children with terminal renal failure

1 reference

12 December 2020

Soft tissue calcification in pediatric patients with end-stage renal disease

1 reference

12 December 2020

22-oxacalcitriol suppresses secondary hyperparathyroidism without inducing low bone turnover in dogs with renal failure

1 reference

12 December 2020

Calcitriol and calcium carbonate therapy in early chronic renal failure.

1 reference

12 December 2020

Renal bone disease in pediatric and young adult patients on hemodialysis in a children's hospital

1 reference

12 December 2020

A prospective, double-blind study of growth failure in children with chronic renal insufficiency and the effectiveness of treatment with calcitriol versus dihydrotachysterol. The Growth Failure in Children with Renal Diseases Investigators

1 reference

12 December 2020

Intermittent oral 1alpha-hydroxyvitamin D2 is effective and safe for the suppression of secondary hyperparathyroidism in haemodialysis patients. 1alphaD2 Study Group

1 reference

12 December 2020

Adynamic renal osteodystrophy: is there a problem?

1 reference

12 December 2020

1 reference

12 December 2020

Effect of 22-oxacalcitriol on hyperparathyroidism of dialysis patients: results of a preliminary study

1 reference

12 December 2020

Renal osteodystrophy in children treated with 1,25-dihydroxy-cholecalciferol [1,25-(OH)2D3]. Histologic bone studies

1 reference

12 December 2020

Low dose calcitriol versus placebo in patients with predialysis chronic renal failure

1 reference

12 December 2020

Aluminum accumulation during treatment with aluminum hydroxide and dialysis in children and young adults with chronic renal disease

1 reference

12 December 2020

Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients

1 reference

12 December 2020

Early diagnosis of juvenile renal osteodystrophy

1 reference

12 December 2020

A novel mechanism for skeletal resistance in uremia

1 reference

12 December 2020

Diminished linear growth during intermittent calcitriol therapy in children undergoing CCPD

1 reference

12 December 2020

Intermittent calcitriol therapy in secondary hyperparathyroidism: a comparison between oral and intraperitoneal administration

1 reference

12 December 2020

Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy

1 reference

12 December 2020

Development of adynamic bone in patients with secondary hyperparathyroidism after intermittent calcitriol therapy

1 reference

12 December 2020

The importance of dietary calcium and phosphorous in the secondary hyperparathyroidism of patients with early renal failure

1 reference

12 December 2020

Intravenous calcitriol in the treatment of refractory osteitis fibrosa of chronic renal failure

1 reference

12 December 2020

Renal osteodystrophy in children with chronic renal failure: an unexpectedly common and incapactating complication

1 reference

12 December 2020

A new analog of calcitriol, 19-nor-1,25-(OH)2D2, suppresses parathyroid hormone secretion in uremic rats in the absence of hypercalcemia

1 reference

12 December 2020

Regression of parathyroid hyperplasia by calcitriol-pulse therapy in patients on long-term dialysis

1 reference

12 December 2020

Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxy-cholecalciferol in uremic patients

1 reference

12 December 2020

Evolution of secondary hyperparathyroidism during oral calcitriol therapy in pediatric renal osteodystrophy

1 reference

12 December 2020

Advanced coronary and carotid arteriopathy in young adults with childhood-onset chronic renal failure

1 reference

12 December 2020

10.1007/S00467-004-1788-2

Identifiers

DOI

1 reference

11 August 2017

1 reference